Peritumoral portal enhancement during transarterial chemoembolization: a potential prognostic factor for patients with hepatocellular carcinoma

BACKGROUND: Tumor response and survival varies in patients treated with transarterial chemoembolization (TACE) for intermediate stage hepatocellular carcinoma (HCC) and may be associated with several factors. PURPOSE: To evaluate safety and efficacy of TACE in patients with intermediate stage HCC an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyman, Sofi Sennefelt, Creusen, Angeliki Dimopoulou, Johnsson, Ulf, Rorsman, Fredrik, Vessby, Johan, Barbier, Charlotte Ebeling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Abdominal and Gastrointestinal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490438/
https://www.ncbi.nlm.nih.gov/pubmed/34665054
http://dx.doi.org/10.1177/02841851211041832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490438/
https://www.ncbi.nlm.nih.gov/pubmed/34665054
http://dx.doi.org/10.1177/02841851211041832

Ejemplares similares